Veterans have poor oral, throat cancer outcomes

August 24, 2015
Veterans have poor oral, throat cancer outcomes

(HealthDay)—In veterans, oropharyngeal squamous cell carcinoma (SCC) is associated with traditional carcinogens and poor clinical outcomes, according to a study published in the September issue of Head & Neck.

Vlad C. Sandulache, M.D., Ph.D., from the Baylor College of Medicine in Houston, and colleagues evaluated patient, tumor, and treatment characteristics for 200 treated for oropharyngeal SCC between 2000 and 2012.

The researchers found that most patients (77 percent) were white and heavy smokers. During treatment, 27 patients required tracheostomy and 63 required gastrostomy placement. At five years, overall survival (OS) was 40 percent. T classification, treatment intensity, completion of treatment, and p16 tumor status all impacted survival. Completion of a treatment regimen consistent with National Comprehensive Cancer Network guidelines was unattainable by almost 30 percent of patients.

"Oropharyngeal SCC in veterans is associated with traditional carcinogens and poor ," the authors write. "Careful consideration must be given to improving treatment paradigms for this cohort given their limited tolerance for treatment escalation."

Explore further: Two cases of SCC described after ingenol mebutate gel application

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Two cases of SCC described after ingenol mebutate gel application

August 10, 2015
(HealthDay)—Two cases of squamous cell carcinoma (SCC) have been described, with rapid onset after application of ingenol mebutate gel for treatment of actinic keratosis (AK). The report was published online July 31 in ...

Periodontitis linked to HPV-positive head, neck tumors

June 20, 2012
(HealthDay) -- For patients with head and neck squamous cell carcinoma (HNSCC) there is an increased risk of human papillomavirus (HPV)-positive tumors among those with a history of periodontitis, according to a study published ...

Study examines chronic inflammation in oral cavity and HPV status of head and neck cancers

June 18, 2012
Among patients with head and neck squamous cell carcinomas, a history of chronic inflammation in the mouth (periodontitis, i.e. gum disease) may be associated with an increased risk of tumors positive for human papillomavirus ...

Prognostic factors identified for peripheral squamous cell carcinomas of the lung

October 24, 2014
A better survival outcome is associated with low blood levels of squamous cell carcinoma antigen, or absence of tumor invasion either into the space between the lungs and chest wall or into blood vessels of individuals with ...

Blood antibodies may predict HPV-positive oropharyngeal cancer survival

June 15, 2015
The presence of certain human papillomavirus (HPV)-16 antibodies in the blood was associated with improved rates of survival among patients with HPV-related oropharyngeal carcinoma.

Superficial X-ray viable for basal, squamous cell carcinoma

August 6, 2012
(HealthDay) -- Superficial X-ray therapy remains a viable treatment for primary basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) in select patients, according to a study published online July 23 in the Journal ...

Recommended for you

Stem cell vaccine immunizes lab mice against multiple cancers

February 15, 2018
Stanford University researchers report that injecting mice with inactivated induced pluripotent stem cells (iPSCs) launched a strong immune response against breast, lung, and skin cancers. The vaccine also prevented relapses ...

Induced pluripotent stem cells could serve as cancer vaccine, researchers say

February 15, 2018
Induced pluripotent stem cells, or iPS cells, are a keystone of regenerative medicine. Outside the body, they can be coaxed to become many different types of cells and tissues that can help repair damage due to trauma or ...

Team paves the way to the use of immunotherapy to treat aggressive colon tumors

February 15, 2018
In a short space of time, immunotherapy against cancer cells has become a powerful approach to treat cancers such as melanoma and lung cancer. However, to date, most colon tumours appeared to be unresponsive to this kind ...

Can our genes help predict how women respond to ovarian cancer treatment?

February 15, 2018
Research has identified gene variants that play a significant role in how women with ovarian cancer process chemotherapy.

First comparison of common breast cancer tests finds varied accuracy of predictions

February 15, 2018
Commercially-available prognostic breast cancer tests show significant variation in their abilities to predict disease recurrence, according to a study led by Queen Mary University of London of nearly 800 postmenopausal women.

Catching up to brain cancer: Researchers develop accurate model of how aggressive cancer cells move and spread

February 15, 2018
A brief chat at a Faculty Senate meeting put two University of Delaware researchers onto an idea that could be of great value to cancer researchers.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.